Virtus ETF Advisers LLC Dexcom Inc Transaction History

Virtus ETF Advisers LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $37,174 - $47,331	337 Added 5.66%	6,294 $713,000
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $680,408 - $834,575	5,957 New	5,957 $826,000
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $226,402 - $263,662	-2,013 Reduced 24.13%	6,328 $813,000
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $867,464 - $1.03 Million	8,341 New	8,341 $969,000
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $432,756 - $845,844	6,365 New	6,365 $474,000
Q4 2019 Feb 13, 2020	SELL	$36.62 - $57.29 $5,859 - $9,166	-160 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$35.53 - $43.8 $1,208 - $1,489	-34 Reduced 17.53%	160 $24,000
Q2 2019 Aug 13, 2019	BUY	$27.84 - $38.92 $5,400 - $7,550	194 New	194 $29,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.